Skip to main content

Perceptive Advisors LLC

SEC CIK
0001224962
Latest filing
Aug 14, 2026

Holdings in Q1 2021

Holdings as of Mar 31, 2021, filed Aug 13, 2021. Long positions only.

Institution overview
Positions
136
No 13F data for Q4 2020
Portfolio value
$7.52B
No 13F data for Q4 2020
Filed
Aug 13, 2021
AmendedSEC

Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.

Holdings of Perceptive Advisors LLC in Q1 2021
SecurityClassSharesValue% of portfolioShare changeActionHistory
PSTXPoseida Therapeutics, Inc.COM787,745$7.52M0.1%––History
TCRRTCR2 Therapeutics Inc.COM313,300$6.92M0.1%––History
TARAProtara Therapeutics, Inc.COM STK421,642$6.64M0.1%––History
DRIODarioHealth Corp.COM NEW327,869$6.31M0.1%––History
AMWLAmerican Well CorpCL A355,000$6.17M0.1%––History
SNDXSyndax Pharmaceuticals IncCOM270,000$6.04M0.1%––History
VINCVincerx Pharma, Inc.COM NEW300,000$5.79M0.1%––History
Catabasis Pharmaceuticals IN14875P206COM NEW1,933,551$5.59M0.1%–––
BCTG Acquisition Corp05492W103COM500,000$5.56M0.1%–––
PHRPhreesia, Inc.COM100,000$5.21M0.1%––History
OBIOOrchestra BioMed Holdings, Inc.ORD SHS450,000$5.04M0.1%––History
Longview Acquisition Corp. II54319Q204UNIT 99/99/9999500,000$5.02M0.1%–––
Consonance HFW Acquisition CG2445M129UNIT 99/99/9999500,000$4.88M0.1%–––
Deerfield Healthcare Tech Ac244413209UNIT 07/16/2025300,000$3.93M0.1%–––
TXMDTherapeuticsMD, Inc.COM2,750,000$3.69M<0.1%––History
MRUSMerus N.V.COM175,000$3.65M<0.1%––History
VRAYViewRay, Inc.COM751,748$3.27M<0.1%––History
TLISTalis Biomedical CorpCOM250,000$3.21M<0.1%––History
SNCEScience 37 Holdings, Inc.COM300,000$3.04M<0.1%––History
SGTXSigilon Therapeutics, Inc.COM125,000$2.79M<0.1%––History
RGNXREGENXBIO Inc.COM69,283$2.36M<0.1%––History
GRTXGalera Therapeutics, Inc.COM254,664$2.25M<0.1%––History
MOTSMotus GI Holdings, Inc.COM1,800,542$2.07M<0.1%––History
PLXPPLx Pharma Winddown Corp.COM222,180$2.01M<0.1%––History
CM Life Sciences Inc18978W109COM CL A127,000$1.89M<0.1%–––
Butterfly Network, Inc.124155110*W EXP 05/27/202233,333$1.50M<0.1%–––
RACEFerrari N.V.COM6,200$1.30M<0.1%––History
EIGREiger BioPharmaceuticals, Inc.COM139,890$1.24M<0.1%––History
Vincerx Pharma, Inc.92731L114*W EXP 12/24/202300,000$1.21M<0.1%–––
SRRASierra Oncology, Inc.COM NEW66,655$1.15M<0.1%––History
SC Health CorpG78516401*W EXP 99/99/999500,000$945.0K<0.1%–––
PHVSPharvaris N.V.COM27,000$755.0K<0.1%––History
Cerevel Therapeutics HLDNG I15678U102*W EXP 06/09/202133,066$573.0K<0.1%–––
CVMCel Sci CorpCOM PAR NEW33,700$513.0K<0.1%––History
SANASana Biotechnology, Inc.COM10,000$335.0K<0.1%––History
Deerfield Healthcare Tech Ac244413100COM CL A20,000$242.0K<0.1%–––

Options (2)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Perceptive Advisors LLC in Q1 2021
SecurityClassPutsCalls
BIIBBiogen Inc.COM$167.8M$209.3M
KYNBKyntra Bio, Inc.COM$6.94M–